Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
1151
Apollo Commercial Real Estate
ARI
$885M
| $14.6M | 0.01% |
760,640
+205,700
| +37% | +$3.88M |
|
|
LTM
1152
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $14.6M | 0.01% |
1,312,990
-130,100
| -9% | -$1.2M |
|
1153
Barclays
BCS
$94.6B
| $14.5M | 0.01% |
1,982,200
-505,601
| -20% | -$3.66M |
|
1154
Allot
ALLT
$388M
| $14.5M | 0.01% |
1,801,626
+11,901
| +0.7% | +$90.7K |
|
1155
Amphastar Pharmaceuticals
AMPH
$858M
| $14.5M | 0.01% |
730,700
+142,700
| +24% | +$2.97M |
|
|
ARCH
1156
DELISTED
Arch Resources, Inc.
ARCH
| $14.5M | 0.01% |
195,100
-6,200
| -3% | -$503K |
|
1157
Old Second Bancorp
OSBC
$1.31B
| $14.4M | 0.01% |
1,179,425
+59,000
| +5% | +$731K |
|
1158
Cemex
CX
$16B
| $14.4M | 0.01% |
3,676,600
+405,300
| +12% | +$1.49M |
|
1159
RPM International
RPM
$14.5B
| $14.4M | 0.01% |
209,100
+106,300
| +103% | +$7.04M |
|
1160
WaFd
WAFD
$2.79B
| $14.4M | 0.01% |
388,700
-174,300
| -31% | -$6.22M |
|
|
HABT
1161
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $14.3M | 0.01% |
1,636,500
-21,016
| -1% | -$197K |
|
1162
Agilysys
AGYS
$3.03B
| $14.2M | 0.01% |
556,400
-38,852
| -7% | -$989K |
|
1163
Bright Horizons
BFAM
$3.76B
| $14.2M | 0.01% |
+93,100
| New | +$14.6M |
|
|
GOGL
1164
DELISTED
Golden Ocean Group
GOGL
| $14.2M | 0.01% |
2,436,381
+593,331
| +32% | +$3.62M |
|
1165
Evolution Petroleum
EPM
$134M
| $14.2M | 0.01% |
2,427,132
+215,644
| +10% | +$1.32M |
|
1166
Rexford Industrial Realty
REXR
$8.11B
| $14.2M | 0.01% |
322,000
-424,400
| -57% | -$18.1M |
|
1167
AptarGroup
ATR
$8.43B
| $14.2M | 0.01% |
119,500
+30,900
| +35% | +$3.74M |
|
1168
Financial Institutions
FISI
$825M
| $14.1M | 0.01% |
468,200
+31,100
| +7% | +$911K |
|
1169
DNOW Inc
DNOW
$3.04B
| $14.1M | 0.01% |
1,231,186
+664,686
| +117% | +$8.21M |
|
1170
Gildan
GIL
$10.6B
| $14.1M | 0.01% |
397,600
+177,000
| +80% | +$6.65M |
|
1171
Oppenheimer Holdings
OPY
$1.23B
| $14.1M | 0.01% |
469,100
+17,700
| +4% | +$509K |
|
|
PARAA
1172
DELISTED
Paramount Global Class A
PARAA
| $14.1M | 0.01% |
324,287
+7,487
| +2% | +$360K |
|
1173
Canadian Natural Resources
CNQ
$98.1B
| $14M | 0.01% |
+1,074,815
| New | +$13.3M |
|
1174
Allegiant Air
ALGT
$2.36B
| $14M | 0.01% |
93,600
+27,000
| +41% | +$3.95M |
|
1175
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $14M | 0.01% |
228,000
+142,900
| +168% | +$8.59M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.